Back
Revance Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
RVNC
Revance Therapeutics
Last Price:
3.84
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.98 | Sell |
| 20-day SMA: | 4.91 | Sell |
| 50-day SMA: | 5.27 | Sell |
| 200-day SMA: | 4.62 | Sell |
| 8-day EMA: | 4.13 | Sell |
| 20-day EMA: | 4.63 | Sell |
| 50-day EMA: | 5.02 | Sell |
| 200-day EMA: | 6.06 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 33.4 | Sell |
| Chaikin Money Flow: | -30034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.15 - 5.83) | Sell |
| Bollinger Bands (100): | (3.71 - 6.29) | Sell |
Revance Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.80 while RVNC 8-day simple moving average is 3.98, which is a Sell signal.
- The stock price of RVNC is 3.80 while Revance Therapeutics 20-day SMA is 4.91, which makes it a Sell.
- Revance Therapeutics 50-day simple moving average is 5.27 while RVNC share price is 3.80, making it a Sell technically.
- RVNC stock price is 3.80 and Revance Therapeutics 200-day simple moving average is 4.62, creating a Sell signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
10
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a Sell
The current Revance Therapeutics [RVNC] share price is $3.80. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
398.63M
Price in USD:
3.80
Share Volume:
1.47M
Revance Therapeutics 52-Week Range
52-Week High:
9.75
52-Week Low:
2.30
Sell
10
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?
The Revance Therapeutics stock price is 3.80 USD today. -
Will RVNC stock go up or go down?
Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Revance Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.80 while RVNC 8-day exponential moving average is 4.13, which is a Sell signal.
- The stock price of RVNC is 3.80 while Revance Therapeutics 20-day EMA is 4.63, which makes it a Sell.
- Revance Therapeutics 50-day exponential moving average is 5.02 while RVNC share price is 3.80, making it a Sell technically.
- RVNC stock price is 3.80 and Revance Therapeutics 200-day simple moving average is 6.06, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
- RVNC Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Revance Therapeutics is a Sell
- Revance Therapeutics Relative Strength Index (RSI) is 33.4, which suggest Revance Therapeutics is oversold
- The Bollinger Bands (25) for Revance Therapeutics is (4.15 - 5.83), which suggest Revance Therapeutics is a Sell
- The Bollinger Bands (100) for Revance Therapeutics is (3.71 - 6.29), which suggest Revance Therapeutics is a Sell
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.